VeriMomgarcinia hanburyi sap powder hamilelikte güvenli mi?
No harmonised CLP reproductive classifications (ECHA Annex VI) or SCCS/CIR safety assessments specific to 'Garcinia hanburyi sap powder' were identified. Peer‑reviewed literature shows bioactive cytotoxic constituents (e.g., gambogic acid) but no conclusive reproductive/developmental data for topical use; therefore default hazard and mechanism scores are 0. Low but potentially measurable dermal absorption is assumed for small lipophilic xanthonoids so exposure scored 1 for pregnancy. Sources checked: ECHA Annex VI (no harmonised CLP), CIR (no assessment found), PubChem/PubMed on gambogic acid (bioactivity but no reproductive classification).
Related ingredients
Frequently asked questions
- garcinia hanburyi sap powder hamilelikte güvenli mi?
- No harmonised CLP reproductive classifications (ECHA Annex VI) or SCCS/CIR safety assessments specific to 'Garcinia hanburyi sap powder' were identified. Peer‑reviewed literature shows bioactive cytotoxic constituents (e.g., gambogic acid) but no conclusive reproductive/developmental data for topical use; therefore default hazard and mechanism scores are 0. Low but potentially measurable dermal absorption is assumed for small lipophilic xanthonoids so exposure scored 1 for pregnancy. Sources checked: ECHA Annex VI (no harmonised CLP), CIR (no assessment found), PubChem/PubMed on gambogic acid (bioactivity but no reproductive classification).
- garcinia hanburyi sap powder emzirirken güvenli mi?
- No specific data indicating reproductive or lactation-related toxicity or harmonised classification. Potential for low dermal absorption of small bioactive constituents suggests low but measurable maternal exposure and theoretical transfer into milk cannot be excluded, so exposure scored 1. No direct evidence of breastmilk transfer or infant effects in prioritized sources (ECHA Annex VI, CIR, PubMed, PubChem).
- garcinia hanburyi sap powder bebek cildi için güvenli mi?
- No infant‑specific reproductive or developmental data were found. Because the ingredient contains small lipophilic xanthonoids (e.g., gambogic acid) that could be dermally absorbed, infant exposure score is increased by +1 from adult exposure (adult e=1 → baby e=2) to reflect immature barrier and higher surface‑area‑to‑weight ratio. No data were found to justify increasing hazard or mechanism scores for infants.
- VeriMom garcinia hanburyi sap powder nasıl puanlıyor?
- VeriMom garcinia hanburyi sap powder'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 93/100 (bilinen risk yok) olarak puanlar.
- Hamilelikte garcinia hanburyi sap powder yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.